Angela Frances Holtham
Independent DirectorMs. Angela Frances Holtham, F.C.M.A., ICD.D, FCPA & M.B.A., has been an Independent Director of Oncolytics Biotech Inc. since June 18, 2014. She served as Chief Financial Officer and Vice President of Finance at The Hospital for Sick Children, Inc. She served a number of positions with Nabisco Canada, the last 5 as Senior Vice President and Chief Financial Officer. She joined Toronto in 2002, Ontario-based Hospital for Sick Children as Vice President, Finance and Chief Financial Officer. Ms. Holtham has experience in supporting finance functions, operations, intellectual property portfolio management and mergers and acquisitions across various roles within the health and wellness and consumer products industries. Through her career she has participated in myriad initiatives ranging from traditional finance functions and operations oversight to intellectual property portfolio management and mergers and acquisitions. She served as Director of Jamieson Wellness Inc. since September 1, 2017 until July 2019. She served as an Independent Director of IBI Group Inc. since March 18, 2015 until May 11, 2017. She has also been a long serving Director with the Certified Management Accountants (CMA). Ms. Holtham was a self-employed professional finance consultant. Ms. Holtham holds a number of governance positions in Canada including: Board Member & chair of the Audit & Risk Management Committee, Ontario Financing Authority (the Nominated for Director Agency that manages the province's debt and investments); Board Director and Audit & Finance Committee member, CMA Canada; and Resources & Audit Committee member, Plexxus (supply chain & IT service provider for 10 GTA hospitals). She serves as Director of Compute Canada. She is a Fellow of the Chartered Professional Accountants of Ontario, a Fellow of the Certified Management Accountants of Canada and holds the ICD.D designation from the Institute of Corporate Directors. Ms. Holtham obtained a Bachelor of Mathematics from the University of Waterloo in 1972 and a Master of Business Administration from the University of Toronto - Rotman School of Management in 1982 and has completed the Institute of Corporate Directors Designation (ICD.D).
Positions
- Company NameOncolytics Biotech Inc.Stock CodeONCYPositionIndependent DirectorColleagues
- JKJared KellyCEO & Director
- WFWayne F. PisanoChairman of the Board
- KJKirk J. LookChief Financial Officer
- TCThomas C. HeinemanChief Medical Officer
- JMJohn McAdoryChief Operating Officer
- AHAllison HagermanChief Technology Officer
- DMDeborah M. BrownIndependent Director
- JMJonathan M. N. RigbyIndependent Director
